Mounting problems lie ahead of medical reform program.

The revised bill of the pharmaceutical affairs law failed to pass through but put it to the next special session of the National Assembly in July that may not open due to the current tax probe over the major press companies, leaving, therefore, many problems unsolved, arising from the medical and pharmacy role separation program including the business collusion between the medical institutes an...